You searched for "blink"
American Academy of Ophthalmology – Updated textbooks Basic and Clinical Science Course 2018-2019
The American Academy of Ophthalmology publish a series of books entitled Basic and Clinical Science Course every year. It’s a highly regarded series and has often been quoted to me as a good reference set of books. Indeed, I invested...Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...VISION 2020 LINKS: Retinoblastoma in Africa
The VISION 2020 LINKS Programme is part of the ‘VISION 2020: The Right to Sight’ global initiative to eliminate avoidable blindness [1]. The LINKS Programme works with overseas eye departments to help identify priorities and match their priority needs with...Blind people let their voices be heard at public speaking event
A group of people with sight loss have taken part in a series of public speaking sessions, with the final event taking place at Glasgow City Chambers in front of a delighted audience.
Ocular surface in donor eyes after CLAU
This retrospective study examined ocular surface stability of donor eyes following conjunctival limbal autografts (CLAU). Forty-five eyes underwent CLAU with chemical burns being the most common indication. All but two eyes had just over 4 o’clock hours of CLAU segment...
Intravitreal triamcinolone for uveitic macular oedema
This paper from South Korea reports on a prospective, double blind, randomised clinical study designed to evaluate the additional benefit of intravitreal triamcinolone (TA) administration for noninfectious uveitic macular oedema as an adjunct therapy to systemic anti-inflammatory treatment. Patients were...
A phase 3 randomised trial of nicotinamide for skin cancer chemoprevention
To B3, or not to B3? That was the question asked in this controlled trial in which the authors were able to show that oral nicotinamide (vitamin B3) is able to reduce further skin cancer development in high risk patients....
